Clinical trials
Completed Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,428 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 33 |
| 2001 | 24 |
| 2002 | 20 |
| 2003 | 33 |
| 2004 | 49 |
| 2005 | 57 |
| 2006 | 52 |
| 2007 | 56 |
| 2008 | 51 |
| 2009 | 73 |
| 2010 | 72 |
| 2011 | 75 |
| 2012 | 68 |
| 2013 | 58 |
| 2014 | 80 |
| 2015 | 78 |
| 2016 | 65 |
| 2017 | 81 |
| 2018 | 68 |
| 2019 | 69 |
| 2020 | 55 |
| 2021 | 49 |
| 2022 | 43 |
| 2023 | 27 |
| 2024 | 18 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,428 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 34 |
| Celgene | 33 |
| Fred Hutchinson Cancer Center | 30 |
| M.D. Anderson Cancer Center | 27 |
| National Cancer Institute (NCI) | 25 |
| Memorial Sloan Kettering Cancer Center | 20 |
| Amgen | 15 |
| AstraZeneca | 14 |
| Bristol-Myers Squibb | 14 |
| H. Lee Moffitt Cancer Center and Research Institute | 13 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 1,428 |
| Multiple Myeloma | 185 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 151 |
| Lymphoma | 141 |
| Leukemia, Myeloid, Acute | 138 |
| Lymphoma, Non-Hodgkin | 134 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 128 |
| Lymphoma, Large B-Cell, Diffuse | 128 |
| Hodgkin Disease | 121 |
| Neoplasms | 113 |
Trials
Showing 1 to 25 of 1,428. Each trial links to its page on Pharma Observatory.
1,328 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.